Teicoplanin: A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy
Brogden RN, Peters DH Teicoplanin: a reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 47:1994;823-854.
Intravenous or intramuscular teicoplanin for skin and soft tissue infection
Edelstein HE, Oster SE, Chirurgi VA, Karp RA, Cassano KB, McCabe RE Intravenous or intramuscular teicoplanin for skin and soft tissue infection. Drug Intell Clin Pharm. 25:1991;914-918.
Outpatient and inpatient teicoplanin treatment for serious gram-positive infections in children
Dagan R, Einhorn M, Howard CB, Williams AH Outpatient and inpatient teicoplanin treatment for serious gram-positive infections in children. Pediatr Infect Dis J. Suppl 12:1993;S17-S20.
A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria
Lewis P, Garaud J-J, Parenti F A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria. J Antimicrob Chemother. 21:1988;61-67.
Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy
Ketley NJ, Kelsey SM, Newland AC Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy. Clin Lab Haematol. 17:1995;71-74.
Teicoplanin thrice weekly for the therapy of infective endocarditis
Vienna, 26-30 March
Graninger W, Wenisch C, Wiesinger E, Presterl E. Teicoplanin thrice weekly for the therapy of infective endocarditis. 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 26-30 March 1995:1203.